Berkshire Hathaway (Berkshire Hathaway), run by “stock god” Buffett, bought a value of 1 billion in the fourth quarter of last year before Microsoft made a bidDollarActivision Blizzard stock, while overweight Chevron (Chevron), but slashed pharmaceutical stocks.
Berkshire (BRK.B-US) held 14.66 million shares of Activision Blizzard (ATVI-US), worth 975 millionDollar。
Microsoft announced on January 18 that it would DollarThe cash premium acquisition of Activision Blizzard inspired the stock to soar 25% on the day, exceeding 82 per share Dollar, although Activision Blizzard’s shares have slipped slightly since then, and are still up 20% this year. Blizzard closed Monday at 81.50 per share Dollarat this price, Buffett’s holdings are worth more than 1 billionDollar。
If the acquisition goes through smoothly, Buffett will make a lot of money. Activision Blizzard’s stock price fell to as low as 56.40 per share in the fourth quarter of last year following it was revealed that it was full of internal disputes such as sexism and long-term sexual harassment culture Dollar。
Overall, Berkshire’s stock-buying interest remained muted in the fourth quarter of last year, with the company selling its holdings for much of the past year. Berkshire will host its annual shareholder meeting on Feb. 26, which will be open to shareholders this year and hosted by Buffett himself.
The 13F document shows that in the fourth quarter of last year, Berkshire emptied two stocks, reduced its holdings of eight stocks, increased its holdings of four stocks, and bought three new stocks.
Berkshire’s fourth quarter investment changes are as follows
According to the 13F report, Berkshire bought nearly 10 million shares of Chevron in the fourth quarter, bringing its total holding to 38.2 million shares worth 5.2 billionDollar。
Berkshire also increased its stake in Brazil’s NU Holdings, which held 107 million shares in the fourth quarter of last year, worth regarding 900 millionDollar. NU is the parent company of Brazilian fintech Nubank, and Berkshire invested $500 million ahead of NU’s initial public offering (IPO) last yearDollar。
In addition, Berkshire continued to reduce the number of pharmaceutical companies, such as AbbVie shares slashed 79% to 3 million shares, Bristol Myers Squibb (Bristol Myers Squibb) shares slashed 76% to 5.2 million shares.In addition, the third quarter originally held a value of 400 millionDollar42 million shares of Teva have been emptied.
Berkshire’s 4th quarter shareholding changes 13F filing:see here
